Amundi Investor Presentation

A financially compelling transaction Key terms of the contemplated transaction High value creation . • • . Acquisition of Lyxor from Société Générale (excl. carved-out activities¹) Total cash consideration of €825m including €70m of excess capital², i.e. purchase price of €755m excluding excess capital - Implied 2021e P/E multiple of ~10x, including run-rate annual cost synergies only³ . Run-rate annual cost synergies of ~€60m (pre-tax), achievable within years post completion • Run-rate annual net revenue synergies of ~€30m (pre-tax) Return on Investment > 10% in year 3 after completion (excluding revenue synergies) and > 13% (including revenue synergies) ~+7% accretive on Amundi's 2021e EPS, including run-rate cost synergies only4 Integration costs of ~€50m post-tax Estimated CET1 capital impact of ~670 bps Regulatory impacts Amundi's pro-forma CET1 ratio of 13.3% as of December 31st 2020, significantly above both its minimum capital requirement and the management target of 10% 1. Certain activities from Lyxor are excluded from the scope of the transaction and retained by Société Générale: (i) structured asset management solutions intended for Société General's global markets clients and (ii) asset management activities dedicated to savings solutions and carried out for Société Générale (Branch networks and Private Banking) such as structuring of saving solutions, funds selection and the supervision of the Société Générale Group's asset management companies. 2. Excess capital vs. asset management regulatory capital requirement applicable to Lyxor the purchase price excluding excess capital, i.e. €755m; calculation accounting for run-rate cost synergies 4. Based on consensus 2021e EPS, accounting for run-rate cost synergies 3. Based on 47 Amundi Investor Presentation - November 2021 Amundi GROUPE CRÉDIT AGRICOLE CREDIT AGRICOLE GROUP

View entire presentation